The Dual Function of RhoGDI2 in Immunity and Cancer

被引:3
|
作者
Tripathi, Mudrika [1 ]
Colige, Alain [1 ]
Deroanne, Christophe F. F. [1 ]
机构
[1] Univ Liege, Lab Connect Tissues Biol, GIGA Canc, B-4000 Liege, Belgium
关键词
RhoGDI2; 1; RhoGDI1; 2; Rho GTPases 3; cancer; 4; immunity; 5; GDP-DISSOCIATION INHIBITOR; LY-GDI; RHO-GTPASES; CELL-PROLIFERATION; BREAST-CANCER; EXPRESSION; INVASION; PROMOTES; MIGRATION; PROTEIN;
D O I
10.3390/ijms24044015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RhoGDI2 is a guanine nucleotide dissociation inhibitor (GDI) specific for the Rho family of small GTPases. It is highly expressed in hematopoietic cells but is also present in a large array of other cell types. RhoGDI2 has been implicated in multiple human cancers and immunity regulation, where it can display a dual role. Despite its involvement in various biological processes, we still do not have a clear understanding of its mechanistic functions. This review sheds a light on the dual opposite role of RhoGDI2 in cancer, highlights its underappreciated role in immunity and proposes ways to explain its intricate regulatory functions.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] RhoGDI2 as a therapeutic target in cancer
    Cho, Hee Jun
    Baek, Kyoung Eun
    Yoo, Jiyun
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (01) : 67 - 75
  • [2] Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis
    Niu, Huiyan
    Li, Hui
    Xu, Can
    He, Ping
    ONCOLOGY REPORTS, 2010, 24 (02) : 465 - 471
  • [3] Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function
    Wu, Yimin
    Moissogiu, Konstadinos
    Wang, Hong
    Wang, Xuejiao
    Frierson, Henry F.
    Schwartz, Martin A.
    Theodorescu, Dan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (14) : 5807 - 5812
  • [4] A Review on the Function and Regulation of ARHGDIB/RhoGDI2 Expression Including the Hypothetical Role of ARHGDIB/RhoGDI2 Autoantibodies in Kidney Transplantation
    Kardol-Hoefnagel, Tineke
    van Logtestijn, Sofie A. L. M.
    Otten, Henny G.
    TRANSPLANTATION DIRECT, 2020, 6 (05): : E548
  • [5] Mechanisms of RhoGDI2 Mediated Lung Cancer Epithelial-Mesenchymal Transition Suppression
    Niu, Huiyan
    Wu, Baogang
    Jiang, Hongfang
    Li, Hui
    Zhang, Yi
    Peng, Yang
    He, Ping
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 34 (06) : 2007 - 2016
  • [6] Overexpression of RhoGDI2 correlates with the progression and prognosis of pancreatic carcinoma
    Yi, Bin
    Zhang, Yi
    Zhu, Dongming
    Zhang, Lifeng
    Song, Shiduo
    He, Songbing
    Zhang, Bing
    Li, Dechun
    Zhou, Jian
    ONCOLOGY REPORTS, 2015, 33 (03) : 1201 - 1206
  • [7] RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer
    Koh, Sung Ae
    Kim, Min Kyoung
    Lee, Kyung Hee
    Kim, Sang Woon
    Kim, Jae-Ryong
    CLINICAL & EXPERIMENTAL METASTASIS, 2014, 31 (07) : 805 - 815
  • [8] RhoGDI2 Expression Is Associated with Tumor Growth and Malignant Progression of Gastric Cancer
    Cho, Hee Jun
    Baek, Kyoung Eun
    Park, Sun-Mi
    Kim, In-Kyu
    Choi, Yeong-Lim
    Cho, Hye-Jung
    Nam, In-Koo
    Hwang, Eun Mi
    Park, Jae-Yong
    Han, Jae Yoon
    Kang, Sang Soo
    Kim, Dong Chul
    Lee, Won Sup
    Lee, Mi-Ni
    Oh, Goo Taeg
    Kim, Jae Won
    Lee, Chang Won
    Yoo, Jiyun
    CLINICAL CANCER RESEARCH, 2009, 15 (08) : 2612 - 2619
  • [9] The faces and friends of RhoGDI2
    Griner, Erin M.
    Theodorescu, Dan
    CANCER AND METASTASIS REVIEWS, 2012, 31 (3-4) : 519 - 528
  • [10] RhoGDI2 confers resistance to 5-fluorouracil in human gastric cancer cells
    Zheng, Zhong
    He, Xiang-Yi
    Li, Jian-Fang
    Yu, Bei-Qin
    Chen, Xue-Hua
    Ji, Jun
    Zhang, Jia-Nian
    Gu, Qin-Long
    Zhu, Zheng-Gang
    Liu, Bing-Ya
    ONCOLOGY LETTERS, 2013, 5 (01) : 255 - 260